3.0600
+0.1500
+(5.15%)
At close: April 17 at 4:00:02 PM EDT
3.0900
+0.03
+(0.98%)
After hours: April 17 at 7:58:31 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BIZILY SCOTT Officer | Conversion of Exercise of derivative security | Sep 16, 2024 | 6,781 |
| CHACKO JACOB M Director | Conversion of Exercise of derivative security | Apr 21, 2023 | 0 |
| KIM ROBERT YOUNG Officer | Conversion of Exercise of derivative security | Feb 5, 2024 | 1,043 |
| KIRN DAVID Chief Executive Officer | Conversion of Exercise of derivative security | Jul 10, 2024 | 1,059,150 |
| MORETTI AUGUST J Chief Financial Officer | Conversion of Exercise of derivative security | May 15, 2023 | 11,045 |
| VIKING GLOBAL INVESTORS LP Beneficial Owner of more than 10% of a Class of Security | Sale | Jan 4, 2024 | -- |
Related Tickers
RGNX REGENXBIO Inc.
5.94
-3.57%
MIST Milestone Pharmaceuticals Inc.
0.8889
+8.80%
CNTB Connect Biopharma Holdings Limited
0.7392
-12.31%
OCUL Ocular Therapeutix, Inc.
7.31
+1.95%
ANNX Annexon, Inc.
1.4600
+2.10%
APLT Applied Therapeutics, Inc.
0.3330
+9.61%
EYPT EyePoint Pharmaceuticals, Inc.
5.68
+2.25%
ATRA Atara Biotherapeutics, Inc.
6.17
+5.65%
ALXO ALX Oncology Holdings Inc.
0.5500
-1.79%
IRD Opus Genetics, Inc.
0.7599
+3.37%